Hillstream Biopharma Correlations

HILSDelisted Stock  USD 0.39  0.01  2.50%   
The current 90-days correlation between Hillstream Biopharma and Virax Biolabs Group is 0.09 (i.e., Significant diversification). The correlation of Hillstream Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Hillstream Biopharma Correlation With Market

Average diversification

The correlation between Hillstream Biopharma and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with Hillstream Stock

  0.7BA Boeing Fiscal Year End 29th of January 2025 PairCorr

Moving against Hillstream Stock

  0.69CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.65AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.62SSNLF Samsung ElectronicsPairCorr
  0.59CSCO Cisco Systems Sell-off TrendPairCorr
  0.59IBM International Business Fiscal Year End 22nd of January 2025 PairCorr
  0.55AXP American Express Fiscal Year End 24th of January 2025 PairCorr
  0.52MCD McDonalds Fiscal Year End 3rd of February 2025 PairCorr
  0.44HPQ HP IncPairCorr
  0.42CVX Chevron Corp Sell-off TrendPairCorr
  0.4DIS Walt Disney Sell-off TrendPairCorr
  0.4MSFT Microsoft Aggressive PushPairCorr
  0.4XOM Exxon Mobil Corp Fiscal Year End 7th of February 2025 PairCorr
  0.38DD Dupont De Nemours Fiscal Year End 4th of February 2025 PairCorr
  0.33BAC Bank of America Aggressive PushPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PALIZVSA
IMMXVRAX
REVBVRAX
IMMXREVB
UNCYBWV
ZVSAVRAX
  
High negative correlations   
UNCYZVSA
UNCYPALI
PALIBWV
ZVSABWV
APGNBWV
UNCYVRAX

Risk-Adjusted Indicators

There is a big difference between Hillstream Stock performing well and Hillstream Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hillstream Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Hillstream Biopharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hillstream Biopharma stock to make a market-neutral strategy. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Still Interested in Hillstream Biopharma?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.